BRWM
ALXN

B. Riley Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

B. Riley Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25
Closed -$4K – 846
2015
Q2 		$4K Sell
25
-100
-80% -$17.3K ﹤0.01% 900
2015
Q1 		$21K Hold
125
– – 0.02% 605
2014
Q4 		$23K Buy
+125
New +$23.2K 0.02% 559
2014
Q3 		– Sell
-1,890
Closed -$295K – 1184
2014
Q2 		$295K Sell
1,890
-4,823
-72% -$762K 0.19% 146
2014
Q1 		$1.02M Buy
+6,713
New +$1.07M 0.75% 19

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return